{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:12:15Z","timestamp":1760044335382},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.ijpharm.2003.09.045","type":"journal-article","created":{"date-parts":[[2003,12,10]],"date-time":"2003-12-10T12:26:08Z","timestamp":1071059168000},"page":"479-489","source":"Crossref","is-referenced-by-count":32,"title":["Serum aminotransferase activity as a predictor of clearance of drugs metabolized by CYP isoforms in rats with acute hepatic failure induced by carbon tetrachloride"],"prefix":"10.1016","volume":"269","author":[{"given":"Koichi","family":"Yokogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harunori","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2003.09.045_BIB1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0076-6879(91)06114-I","article-title":"Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function","volume":"206","author":"Arlotto","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0009-9236(99)90058-9","article-title":"Dosing recommendation in liver disease","volume":"66","author":"Bergquist","year":"1999","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB3","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/0006-2952(85)90355-7","article-title":"Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450","volume":"34","author":"Burke","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0024-3205(96)00132-4","article-title":"Effect of cytochrome P450 2B1 modulator on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats","volume":"58","author":"Chen","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0","article-title":"Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species","volume":"18","author":"Court","year":"1997","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1006\/bbrc.1993.2601","article-title":"Identification of cytochromes P450 1A2, 2A1, 2C7, 2E1 in rat glioma C6 cell line by RT-PCR and specific restriction enzyme digestion","volume":"197","author":"Geng","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0006-2952(94)90524-X","article-title":"Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics","volume":"47","author":"Girre","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB8","first-page":"1189","article-title":"Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples","volume":"256","author":"Guengerich","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0773.1996.tb00185.x","article-title":"Relationship between mephenytoin, phenytoin and tolbutamide hydroxylations in healthy African subjects","volume":"78","author":"Horsmans","year":"1996","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0168-8278(05)80187-4","article-title":"Measuring lidocaine metabolite\u2014monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis","volume":"19","author":"Huang","year":"1993","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1211\/0022357011776036","article-title":"Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure","volume":"53","author":"Huang","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/bbrc.1998.8665","article-title":"The detection of cytochrome P450 2E1 and its catalytic activity in rat testis","volume":"246","author":"Jiang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1254\/jjp.24.195","article-title":"Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome P-450 and aniline-induced P-450 difference spectrum","volume":"24","author":"Kamataki","year":"1974","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0300-2977(96)00002-2","article-title":"Cytochrome P450 isoenzymes\u2014importance for the internist","volume":"48","author":"Kerremans","year":"1996","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1248\/bpb.24.1305","article-title":"Application of the PKCYP-test to predict the amount of in vivo CYP2C11 using tolbutamide as a probe","volume":"24","author":"Matunaga","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002040050666","article-title":"Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats","volume":"74","author":"Mizuno","year":"2000","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.1840180528","article-title":"Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication","volume":"18","author":"Nakatsukasa","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj3090055","article-title":"Hormonal regulation of zonated expression of cytochrome p-450 3A in rat liver","volume":"309","author":"Omonen","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB20","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1210\/en.141.11.4100","article-title":"Nominal growth hormone pulses in otherwise normal masculine plasma profiles induce intron retention of overexpressed hepatic CYP2C11 with associated nuclear splicing deficiency","volume":"141","author":"Pampori","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1248\/bpb1978.11.785","article-title":"Effect of cimetidine on lidocaine distribution in rat","volume":"11","author":"Shibasaki","year":"1988","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.1995.tb04412.x","article-title":"CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients","volume":"39","author":"Sotaniemi","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0378-4347(92)80163-K","article-title":"Simultaneous determination of caffeine and its primary demethylated metabolites in human plasma by high-performance liquid chromatography","volume":"575","author":"Tanaka","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2710.1998.00135.x","article-title":"Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease","volume":"23","author":"Tanaka","year":"1998","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1994.tb00338.x","article-title":"Changes in caffeine, lidocaine and trimethadione metabolism in carbon tetrachloride-intoxicated rats as assay by a cocktail study","volume":"75","author":"Tanaka","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB26","first-page":"336","article-title":"A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethyl metabolites","volume":"30","author":"Tanaka","year":"1992","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1349-7006.1995.tb03080.x","article-title":"Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production","volume":"86","author":"Waki","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB28","first-page":"1149","article-title":"Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function","volume":"26","author":"Wensing","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ijpharm.2003.09.045_BIB29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517303005623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517303005623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T12:53:06Z","timestamp":1623588786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517303005623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0378517303005623"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2003.09.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}